Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury 
.

CONCLUSION: Paricalcitol may attenuate renal tubular injury caused by IRI by decreasing both level and expression of MMPs. Further studies are required to investigate the interplay between activated vitamin D and MMPs in AKI.
.
PMID: 28737133 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - July 24, 2017 Category: Urology & Nephrology Authors: Ersan S, Celik A, Tanrisev M, Kose I, Cavdar Z, Unlu M, Kocak A, Ural C, Yilmaz B, Kose T Tags: Clin Nephrol Source Type: research